Literature DB >> 22807191

Power of the Mantel-Haenszel and other tests for discrete or grouped time-to-event data under a chained binomial model.

John M Lachin1.   

Abstract

Power for time-to-event analyses is usually assessed under continuous-time models. Often, however, times are discrete or grouped, as when the event is only observed when a procedure is performed. Wallenstein and Wittes (Biometrics, 1993) describe the power of the Mantel-Haenszel test for discrete lifetables under their chained binomial model for specified vectors of event probabilities over intervals of time. Herein, the expressions for these probabilities are derived under a piecewise exponential model allowing for staggered entry and losses to follow-up. Radhakrishna (Biometrics, 1965) showed that the Mantel-Haenszel test is maximally efficient under the alternative of a constant odds ratio and derived the optimal weighted test under other alternatives. Lachin (Biostatistical
Methods: The Assessment of Relative Risks, 2011) described the power function of this family of weighted Mantel-Haenszel tests. Prentice and Gloeckler (Biometrics, 1978) described a generalization of the proportional hazards model for grouped time data and the corresponding maximally efficient score test. Their test is also shown to be a weighted Mantel-Haenszel test, and its power function is likewise obtained. There is trivial loss in power under the discrete chained binomial model relative to the continuous-time case provided that there is a modest number of periodic evaluations. Relative to the case of homogeneity of odds ratios, there can be substantial loss in power when there is substantial heterogeneity of odds ratios, especially when heterogeneity occurs early in a study when most subjects are at risk, but little loss in power when there is heterogeneity late in a study.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22807191      PMCID: PMC3634579          DOI: 10.1002/sim.5480

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Sample sizes based on the log-rank statistic in complex clinical trials.

Authors:  E Lakatos
Journal:  Biometrics       Date:  1988-03       Impact factor: 2.571

3.  The power of the Mantel-Haenszel test for grouped failure time data.

Authors:  S Wallenstein; J Wittes
Journal:  Biometrics       Date:  1993-12       Impact factor: 2.571

4.  Regression analysis of grouped survival data with application to breast cancer data.

Authors:  R L Prentice; L A Gloeckler
Journal:  Biometrics       Date:  1978-03       Impact factor: 2.571

5.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Interpretation of statistical methodology associated with maintenance trials.

Authors:  G G Koch; I McCanless; J F Ward
Journal:  Am J Med       Date:  1984-11-19       Impact factor: 4.965

8.  Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.

Authors:  J M Lachin; M A Foulkes
Journal:  Biometrics       Date:  1986-09       Impact factor: 2.571

  8 in total
  3 in total

1.  Sample size calculation for studies with grouped survival data.

Authors:  Zhiguo Li; Xiaofei Wang; Yuan Wu; Kouros Owzar
Journal:  Stat Med       Date:  2018-06-10       Impact factor: 2.373

2.  Practical considerations when analyzing discrete survival times using the grouped relative risk model.

Authors:  Rachel MacKay Altman; Andrew Henrey
Journal:  Lifetime Data Anal       Date:  2017-10-11       Impact factor: 1.588

3.  Study of emotional distress in a comparative effectiveness trial of diabetes treatments: Rationale and design.

Authors:  Andrea L Cherrington; Heidi Krause-Steinrauf; Ionut Bebu; Aanand D Naik; Elizabeth Walker; Sherita H Golden; Jeffrey S Gonzalez
Journal:  Contemp Clin Trials       Date:  2021-03-22       Impact factor: 2.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.